Metraipolis › archive › dc_f0ebead6beb7

PEGylated IL2 and tumor-targeted radiotherapy augment CD8+ T cell-mediated anti-tumor response to anti-PD-1 in head and neck squamous cell carcinoma — Europe PMC PMID:42708038

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42708038
DOI
10.7150/thno.135255
License (as archived)
solo-consultazione
Archived
2026-10-16T20:29:17.780Z
SHA-256 of the archived text
8b433c23c4027353c8f76eaf34baa7af9830668e7502ef8574e59228fc1348ee
Stable URL of this page
https://metraipolis.com/documento/dc_f0ebead6beb7

How to cite

PEGylated IL2 and tumor-targeted radiotherapy augment CD8+ T cell-mediated anti-tumor response to anti-PD-1 in head and neck squamous cell carcinoma — Europe PMC PMID:42708038 — Europe PMC (en), https://europepmc.org/article/MED/42708038 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f0ebead6beb7 (Metraipolis archive dc_f0ebead6beb7, sha256 8b433c23c4027353c8f76eaf34baa7af9830668e7502ef8574e59228fc1348ee)
BibTeX
@misc{dcf0ebead6beb7,
  title = {PEGylated IL2 and tumor-targeted radiotherapy augment CD8+ T cell-mediated anti-tumor response to anti-PD-1 in head and neck squamous cell carcinoma — Europe PMC PMID:42708038},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42708038},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f0ebead6beb7; sha256 8b433c23c4027353c8f76eaf34baa7af9830668e7502ef8574e59228fc1348ee},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42708038. Agents can read the archived copy with the MCP tool read_document.